Loxo Oncology, Inc. logo

Loxo Oncology, Inc.

12 Marks
Corp.
First Filed:Apr 12, 2016Latest Filed:Nov 13, 2017Address:Stamford, CT 06901

Portfolio Overview

Dead
12(100%)

Top Classes

Class 5
Pharmaceuticals
10(83%)
Class 42
Software, IT Services & Scientific Research
2(17%)

TTAB Proceedings

No litigation activity

Top Firms

ELI LILLY AND COMPANY(Nov 2017)
6
Fish & Richardson P.C.(Sep 2017)
6

Trademark Portfolio

12 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
LOXO
LOXO
Trademark
Stylized
ABANDONED
Owner:
Serial:87682768
Filed:Nov 13, 2017
Classes:5
LOXO
LOXO
Trademark
Word
CANCELLED
Owner:
Serial:87678521
Filed:Nov 9, 2017
Classes:5
Registration:5776463
Registered:Jun 11, 2019
Goods & Services
Pharmaceutical preparations for the treatment of cancer, autoimmune disease and immunologic-based disease; therapeutic pharmaceutical for the treatment of cancer, autoimmune disease and immunologic-based disease; full line of pharmaceutical preparations for cancer, autoimmune disease and immunologic-based disease
LOXO
LOXO
Service Mark
Combined
ABANDONED
Owner:
Serial:87678531
Filed:Nov 9, 2017
Classes:42
LOXO
LOXO
Trademark
Combined
ABANDONED
Owner:
Serial:87678528
Filed:Nov 9, 2017
Classes:5
LOXO
LOXO
Service Mark
Word
ABANDONED
Owner:
Serial:87678525
Filed:Nov 9, 2017
Classes:42
EXTENTRAK
EXTENTRAK
Trademark
Word
ABANDONED
Owner:
Serial:87614116
Filed:Sep 19, 2017
Classes:5
Goods & Services
Class 005: Pharmaceutical preparations for the treatment of cancer, autoimmune disease and immunologic-based disease; therapeutic pharmaceutical for the treatment of cancer, autoimmune disease and immunologic-based disease; full line of pharmaceutical preparations for cancer, autoimmune disease and immunologic-based disease
KIZMETRAK
KIZMETRAK
Trademark
Word
ABANDONED
Owner:
Serial:87614196
Filed:Sep 19, 2017
Classes:5
Goods & Services
Class 005: Pharmaceutical preparations for the treatment of cancer, autoimmune disease and immunologic-based disease; therapeutic pharmaceutical for the treatment of cancer, autoimmune disease and immunologic-based disease; full line of pharmaceutical preparations for cancer, autoimmune disease and immunologic-based disease
OSIDNA
OSIDNA
Trademark
Word
ABANDONED
Owner:
Serial:86972629
Filed:Apr 12, 2016
Classes:5
REVTREK
REVTREK
Trademark
Word
ABANDONED
Owner:
Serial:86972637
Filed:Apr 12, 2016
Classes:5
RIELTOS
RIELTOS
Trademark
Word
ABANDONED
Owner:
Serial:86972633
Filed:Apr 12, 2016
Classes:5
TRAKEMPO
TRAKEMPO
Trademark
Word
ABANDONED
Owner:
Serial:86972631
Filed:Apr 12, 2016
Classes:5
TRAKYBA
TRAKYBA
Trademark
Word
ABANDONED
Owner:
Serial:86972634
Filed:Apr 12, 2016
Classes:5

Cookie Preferences

We use cookies (including Google Analytics) to improve our site and understand how visitors use it.

View our privacy policy